Industry Gets Breathing Space For Post-Brexit Regulation In Northern Ireland
One-Year Phase-In Period Addresses Pharma’s ‘Cliff Edge’ Concerns
The pharmaceutical industry has welcomed a decision to allow more time to bring in new medicines regulations in Northern Ireland, but continues to insist that a mutual recognition agreement between the UK and the EU on drug manufacturing is the best way forward.
